|Branche: Healthcare/Gesundheitswesen||Heimatland: Kanada||WKN: A140QA||Börsensymbol Deutschland: 11L1|
|Unterkategorie: Cannabis||Börsensymbol Kanada: WEED||ISIN: CA1380351009||Ausstehende Aktien: 343.030.000|
- Cannabis-Aktien: Unternehmen aus Deutschland, USA, Kanada profitieren von der Legalisierung!
- Top-Aktie für 2023: Wird das die beste deutsche Aktie im Jahr 2023?
- Green Rush: Vom neuen Cannabis-Boom profitieren!
- Aurora Cannabis, Canopy Growth & Co mit Lebenszeichen: Positive News aus den USA
- Why Innovative Industrial Properties, Hillenbrand, and Canopy Growth Slumped Today
- 43 Cannabis-Raketen - hier sehen Sie die überraschenden Kursziele der Analysten!
- Canopy Growth: Und es geht weiter
- Aurora-Cannabis-Rivale Canopy Growth: Und es geht weiter
- Canopy Growth: Und es geht weiter
- Acreage Holdings, Inc.: Acreage Implements Previously Announced Plan of Arrangement with Canopy Growth
MD&A Quarterly zum 31.12.2018
CONSOLIDATED FINANCIAL STATEMENTS
Condensed Interim Consolidated Financial
FOUNDER, CHAIRMAN and CO-CEO
Mr. Linton is the founder of Canopy Growth Corporation (CGC) and co-founder of Tweed Marijuana Incorporated. Canopy Growth was the first cannabis producing company in North America to be listed on a major stock exchange (TSX, July 2016) and included on a major stock index (S&P/TSX Composite Index, March 2017). In May 2018 Canopy was also the first cannabis-producing company to list on another major stock exchange, the New York Stock Exchange. Bruce’s experience as a founder, CEO, and Board member across a wide variety of enterprises has influenced the positive start of Canopy Growth, which to date has enjoyed market support for capital raises of over $6 billion including a $5 billion investment by Fortune 500 beverage company, Constellation Brands (NYSE:STZ).
Bruce’s focus has been driving the Company’s overall strategy including its Canadian and international expansion efforts as well as laying the groundwork for the Company’s future move into cannabis-based consumer products including cannabis-based medicines, with the founding of subsidiary Canopy Health Innovations, and into cannabis-based beverages, through a strategic partnership with Constellation Brands. After beginning his career at Newbridge Networks Corporation, he has since held positions that include General Manager and Re-Founder of Computerland.ca, President and Co-Founder of webHancer Corp, and part of the establishing team at CrossKeys Systems Corporation. He was also part of the leadership team for the NASDAQ/TSX initial public offering at CrossKeys. He is the past Chairman of the Ottawa Community Loan Foundation past Board Member and Treasurer of Canada World Youth, past Board of Governor for Carleton University, past President of the Nepean Skating Club, and past President of the Carleton University Students Association.
PRESIDENT AND CO-CEO
Mark is the President and Co-CEO of Canopy Growth Corporation. With Canopy since its inception, Mark has been a key driver of the Tweed and Canopy Growth vision, ensuring that patients and healthcare practitioners choose Canopy companies as their trusted source of cannabis for medical purposes. This includes overseeing medical and patient outreach strategy, driving operations and advancing corporate market strategy.
A graduate from the University of Waterloo in Mathematics, the University of Ottawa in Law, and the University of Cambridge in International Law, Mark has previously kept himself busy providing legal, political and strategic advice to high- profile local and international corporate clients, most recently as Counsel at the Ottawa-Washington international trade law firm of Cassidy Levy Kent. Previously, Mark has served as a Senior Advisor to the Honourable Dwight Duncan, the Ontario Minister of Finance, and has worked internationally at the Business and Industry Advisory Committee to the Organization for Economic Co-operation and Development (OECD).
EXECUTIVE VICE PRESIDENT AND CHIEF FINANCIAL OFFICER
Tim is a finance executive with international experience in public companies and private equity-backed start-ups. His leadership style focuses on business transformation and forward thinking to advance business capability and the business model. Tim joined Canopy Growth Corporation as the Chief Financial Officer in June 2015. Since joining the company, Tim has managed multiple financings that have raised over $6 billion and directed strategic corporate acquisitions that increased the company’s production capacity, brand strength and global business footprint. In addition, Mr. Saunders facilitated the July 2016 uplisting of the company’s shares to the Toronto Stock Exchange – making Canopy the first cannabis company to be listed on a major global stock exchange and later the first to be on the S&P TSX Index. Tim’s leadership was instrumental to listing the company’s shares on the New York Stock Exchange (NYSE) in May 2018. Prior to joining Canopy, Tim held executive finance positions at Mitel, Zarlink Semiconductor, Vodafone (UK/Czech Republic), Oskar Mobil (Czech Republic) and Plasco Energy Group.
Tim earned his CPA, CA with PricewaterhouseCoopers and is a proud graduate of Bishop’s University (Quebec) where he obtained his BBA. Tim also earned an executive certificate from the Ivey School of Business at the University of Western Ontario.
Chief Legal Officer
As Chief Legal Officer, Phil is responsible for Canopy’s reporting obligations as a publicly traded TSX listed company as well as all the company’s other legal needs. He also leads Canopy’s human resources department and is intimately involved in business development. Phil joined Canopy in 2016 after almost a decade as General Counsel at Conversant Intellectual Property Management Inc. (formerly MOSAID Technologies Inc.), where he implemented key changes to its equity and shareholder rights plans, and to its corporate governance practices. While there, he was also the lead in-house attorney during one of Canada’s first proxy battles, led by a U.S hedge fund, in which an alternative slate of directors was proposed, as well as during a hostile bid which resulted in the company going private. Prior to that he worked at McCarthy Tétrault LLP. Phil obtained his Bachelor of Laws (LLB) from the University of Windsor in 2000, and holds a Bachelor of Arts in English Literature (with a minor in French) from Université Laval. Phil received the Ottawa Business Journal’s Top 40 under 40 Award in 2008 and was a finalist in Lexpert®’s Rising Stars—Leading Lawyers Under 40, in 2011.
EXECUTIVE VICE PRESIDENT
Formerly the Senior Vice President, Sales & Operations, Rade is responsible for our Canadian strategy and ensuring full coordination among our operations.
Rade began investing his savings in the Toronto Stock Exchange at the age of 8, opened an e-commerce firm at age 13, interned at a stock brokerage before he had completed high school, and operated a medical cannabis dispensary for almost a decade. He has a history of being able to bring key stakeholders together on marijuana policy, as a Co-Founder and former President of the Canadian Association of Medical Cannabis Dispensaries and a Co-Founder and former Advocacy Committee Chair of the Canadian Medical Cannabis Industry Association.
Rade has long been active in his local business community with the Guelph Young Professionals Network, Guelph Chamber of Commerce, Toronto Board of Trade, Ontario Chamber of Commerce, and Ontario Economic Summit having worked to develop policy to ensure Canada continues to be a supportive environment for both business and its citizens. He focused on Management Economics and Industry Finance while completing his Bachelor of Arts degree at the University of Guelph.
VICE PRESIDENT MEDICAL
Amanda oversees the medical strategy for Canopy Growth including the medical sales team, and the creation and implementation of continuing medical education (CME) programs for healthcare professionals.
Before joining Canopy Growth in the spring of 2014, Amanda spent 15 years in the pharmaceutical industry. Over the years she held various positions in sales and medical education, most recently spending just over a decade at Pfizer Canada where she was Regional Manager, Health Education. The majority of her time was spent on the pain portfolio as a member of the Ontario Pain Leadership Team. Additional therapeutic areas in which she has focused include neurology, gastroenterology, mental health and cardiovascular medicine, with exposure to brands in all stages of the life cycle from launch to loss of exclusivity (LOE). Amanda has received several accolades throughout her career, including a leadership award for her role as Regional Manager, Health Education, with Pfizer Canada. As for giving back to the community, Amanda has dedicated her time to volunteering with the City of Ottawa Public Health Department and was recognized by the Government of Canada for her volunteer work at the G7 Summit in Halifax.
SENIOR VICE PRESIDENT, GLOBAL QUALITY ASSURANCE AND CHIEF SCIENCE OFFICER
From the construction of the Smiths Falls facility and sale of the first batch, to the development of Tweed’s in-house laboratory, Tom’s number one priority has always been ensuring the safety and quality of our products.
Tom studied Biopharmaceutical Sciences specializing in Genomics at the University of Ottawa. His toxicology research, while at Health Canada, focused on the effects common materials in our environment such as printer toner, paint, sunblock, tobacco smoke and road-side dust have on DNA mutations.
Upon completion of the research, he transferred to the Center for Vaccine Evaluation of Health Canada. There he reviewed vaccine production practices and performed testing on a variety of vaccines including influenza, hepatitis, yellow fever and rotavirus. He also contributed to the development of new testing methods of vaccines to replace traditional animal testing methods.
Tom’s scientific knowledge and experience in toxicology, biopharmaceuticals, and drug regulations all contribute to his effectiveness as Vice President of Quality Assurance.
CHIEF COMMERCIAL OFFICER, RECREATIONAL CANNABIS
David is a senior marketing and sales executive with deep expertise across consumer goods. Prior to joining Canopy Growth Corporation as Chief Marketing Officer in August 2017, David served as both Vice-President, Marketing and Vice-President, Sales for Molson Coors Canadian operations. Over his time at Molson Coors, David led the marketing team to top marketing honours in 2010, 2011 and 2014 before moving to sales in 2015. Under David’s leadership Molson’s brand valuation increased by $137M over a 6-year period. David is renowned as a change agent who motivates teams through a clear vision, a collaborative leadership style and entrepreneurial approach.
David holds an Honours Bachelor of Business Administration (Marketing) with a minor in Economics, from Wilfrid Laurier University (1995). David’s career includes progressive roles with both Unilever and Venture Communications as well as having served on the board of The Beer Store. David’s passion for inspiring innovation has lead him to frequently share his insight and perspective within the Canadian marketing industry and is a frequent speaker at Canadian Universities.
CHIEF INFORMATION OFFICER
Ru joined Canopy Growth Corporation in September 2016 as the Chief Information Officer. Prior to joining Canopy Growth, Ru was the Chief Information Officer and Vice President of Professional Services at March Networks. Ru joined March Networks in 2010 as CIO, overseeing a successful business transformation and Enterprise Resource Planning (ERP) implementation. In June of 2012, he assumed the additional responsibility for Professional Services which included Managed Services, Technical Support and Training. He was accountable for profit and loss for services. Prior to joining March Networks, Ru spent close to 20 years at Nortel Networks where he held leadership positions in IT, product management and operations.
Ru holds a Bachelor’s degree in Engineering from Carleton University and a Master’s degree in Business from the University of Ottawa. Ru was awarded a U.S. patent in networking in 2008.
Tweed is the most recognized cannabis brand in the world. It has built a large and loyal following by focusing on quality products and meaningful customer relationships. Tweed doesn’t just sell cannabis, it facilitates a conversation about a product we’ve all heard about but haven’t met intimately yet. It is approachable and friendly, yet reliable and trusted.
Spectrum Cannabis is Canopy Growth’s international medical brand, serving as the Company’s healthcare professional and patient-facing identity in medical markets in Canada and around the world. Spectrum Cannabis is focused on the simplification of healthcare interactions, stakeholder outreach, and patient education, applying a colour-coded Spectrum to classify cannabis that tens of thousands of Canadians rely on each day. With a presence in multiple jurisdictions across several continents, our industry-leading expertise developed in Canada is now available around the world through the Spectrum Cannabis brand.
DNA Genetics have won awards in every category in the Cannabis Cup, the world’s preeminent cannabis competition. They are, simply put, global breeding and growing legends. DNA has partnered with us to ensure all that knowledge and experience is put to good use as we continually iterate through growing and curing processes to arrive at nothing short of perfection. Working with DNA, we develop while breeding new strains for customers that simply aren’t available anywhere else in the world, bringing the best of existing DNA genetics to our customers, bred and grown to the DNA standards the world expects.
We believe there is a place for producers big and small in the cannabis sector, and are putting action to our words. Our approach with CraftGrow and Spectrum Cannabis is to establish a diverse online marketplace for legal medical cannabis products. People can seamlessly access Canada’s leading cannabis brands with one medical document rather than being tied to a single producer. For new producers, having access to the largest group of registered patients in the country can go a long way towards building brand awareness. It is also our way of supporting expedited speed to market for newly licensed producers. CraftGrow partnerships represent a win-win-win model for Canadian patients, the CraftGrow partners, and Canopy Growth.
Tokyo Smoke is an award-winning, design-focused company that seamlessly blends the best of cannabis with preeminent retail. Tokyo Smoke is ushering in a new era with an elevated and immersive retail experience featuring it’s signature collection of accessories and line of recreational cannabis.
DOJA is a licensed producer based in British Columbia’s picturesque Okanagan Valley, where DOJA proudly grows premium, hand-crafted flower. Born with a rebellious spirit and respect for the land, DOJA always stays true to its West Coast roots proudly representing those “Of a Different Strain.”
Van der Pop
Van der Pop is one of North America’s most recognized female-focused cannabis businesses. With a focus on education and community, Van der Pop is a guide helping women discover and pursue new paths to self-care and happiness.
Maitri is a leading Quebec-based accessory business proudly founded in Montreal. Building off the success of their thoughtfully-designed line of cannabis accessories, Maitri was recently nominated for “Brand of the Year” at the Canadian Cannabis Awards. Maitri continues to evolve, growing an active community of Quebecois cannabis enthusiasts.
Investorenveranstaltungen und nächste Termine:
Q4 and FY19 Financial Results – June 28, 2019 *
Q1 FY20 Financial Results – August 14, 2019 *
Q2 FY20 Financial Results – November 14, 2019 *
Q3 FY20 Financial Results – February 14, 2020 *
* Dates are tentative and subject to change. Date and conference call details will be confirmed in a press release approximately 1 week prior.
- Operations in over a dozen countries on 5 continents
- 10 world-class production facilities in Canada
- Commercial scale operations incl. oil extraction & soft gel production
- 4.3 M sq. ft. licensed / 1.3M sq. ft. expansion underway
- Global medical cannabis leadership
- Product innovation and education
Canadian Medical Market Leader
- 83,000+ Patients
- 56,000+ Healthcare Professional Visits